Latest filing published 12 Sept 2025 for TG Therapeutics, INC., €573k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Sagar Lonial, listed as board member, appears in our data through filings on TG Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 22 June 2020 to 11 September 2025, the count stands at 12 filings.
The open-market record consists of 6 sales worth €1.9M, with no purchase. The rest of the record consists of 6 share grants. 2025 to date brings no purchases and 1 sale.
The newest entry dates from 12 September 2025: an open-market sale of €573k, in TG Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations